|
NRAS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.568400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.335960E-01 |
| Normal-vs-Stage2 |
4.525600E-01 |
| Normal-vs-Stage3 |
1.984600E-01 |
| Normal-vs-Stage4 |
7.386400E-01 |
| Stage1-vs-Stage2 |
7.655800E-01 |
| Stage1-vs-Stage3 |
1.326300E-02 |
| Stage1-vs-Stage4 |
3.109600E-01 |
| Stage2-vs-Stage3 |
9.846100E-02 |
| Stage2-vs-Stage4 |
4.298000E-01 |
| Stage3-vs-Stage4 |
6.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.291800E-01 |
| Normal-vs-AfricanAmerican |
3.742400E-01 |
| Normal-vs-Asian |
8.409200E-01 |
| Caucasian-vs-AfricanAmerican |
8.349400E-01 |
| Caucasian-vs-Asian |
7.310400E-01 |
| AfricanAmerican-vs-Asian |
7.085000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.832200E-02 |
| Normal-vs-Female |
1.428170E-01 |
| Male-vs-Female |
1.322840E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.303000E-01 |
| Normal-vs-Extreme_Weight |
3.843900E-02 |
| Normal-vs-Obese |
7.270400E-01 |
| Normal-vs-Extreme_Obese |
3.843000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.926000E-01 |
| Normal_Weight-vs-Obese |
7.401400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.448800E-01 |
| Extreme_Weight-vs-Obese |
1.201420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.243800E-01 |
| Obese-vs-Extreme_Obese |
6.620200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.962400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.637800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.417900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.954600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.812600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.253150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.779820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.494200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.227800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.969900E-02 |
| Normal-VS-Type2 PRCC |
4.465800E-01 |
| Normal-VS-KIRP CIMP |
2.030400E-01 |
| Normal-VS-Unclassified PRCC |
4.358000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.664700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.324350E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.163900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.868200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.636200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.444600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.340000E-01 |
| Normal-vs-N1 |
5.976400E-02 |
| Normal-vs-N2 |
7.531400E-01 |
| N0-vs-N1 |
2.018100E-02 |
| N0-vs-N2 |
4.076600E-01 |
| N1-vs-N2 |
6.465400E-01 |
|
|
